CN102274271A - Soybean plantworms mycelium powder and preparation method thereof - Google Patents
Soybean plantworms mycelium powder and preparation method thereof Download PDFInfo
- Publication number
- CN102274271A CN102274271A CN201010199789XA CN201010199789A CN102274271A CN 102274271 A CN102274271 A CN 102274271A CN 201010199789X A CN201010199789X A CN 201010199789XA CN 201010199789 A CN201010199789 A CN 201010199789A CN 102274271 A CN102274271 A CN 102274271A
- Authority
- CN
- China
- Prior art keywords
- semen sojae
- sojae atricolor
- powder
- cordyceps
- mycelium powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 title claims abstract description 96
- 244000068988 Glycine max Species 0.000 title claims abstract description 23
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 35
- 238000000855 fermentation Methods 0.000 claims abstract description 19
- 230000004151 fermentation Effects 0.000 claims abstract description 19
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims abstract description 15
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 13
- 239000005017 polysaccharide Substances 0.000 claims abstract description 13
- 150000004676 glycans Chemical class 0.000 claims abstract description 12
- 150000001413 amino acids Chemical class 0.000 claims abstract description 10
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims abstract description 8
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 8
- 229960005305 adenosine Drugs 0.000 claims abstract description 8
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 8
- 235000005911 diet Nutrition 0.000 claims abstract description 7
- 230000037213 diet Effects 0.000 claims abstract description 7
- 230000001954 sterilising effect Effects 0.000 claims abstract description 5
- 238000002791 soaking Methods 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 92
- 241000190633 Cordyceps Species 0.000 claims description 86
- 241000222336 Ganoderma Species 0.000 claims description 52
- 240000001080 Grifola frondosa Species 0.000 claims description 43
- 235000007710 Grifola frondosa Nutrition 0.000 claims description 43
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 23
- 239000002775 capsule Substances 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000007902 hard capsule Substances 0.000 claims description 8
- 235000015173 baked goods and baking mixes Nutrition 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 7
- 235000013557 nattō Nutrition 0.000 claims description 7
- 235000011888 snacks Nutrition 0.000 claims description 7
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 6
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 6
- 235000008696 isoflavones Nutrition 0.000 claims description 6
- 235000018102 proteins Nutrition 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 229910001220 stainless steel Inorganic materials 0.000 claims description 6
- 239000010935 stainless steel Substances 0.000 claims description 6
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 6
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 6
- 229930187719 Soyasaponin Natural products 0.000 claims description 5
- 229920001542 oligosaccharide Polymers 0.000 claims description 5
- 150000002482 oligosaccharides Polymers 0.000 claims description 5
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 claims description 4
- 235000008429 bread Nutrition 0.000 claims description 4
- 235000014510 cooky Nutrition 0.000 claims description 4
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 claims description 4
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- 241000238557 Decapoda Species 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 230000008961 swelling Effects 0.000 claims description 3
- 235000013311 vegetables Nutrition 0.000 claims description 3
- 241000195474 Sargassum Species 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 230000009286 beneficial effect Effects 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 239000011812 mixed powder Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000005491 wire drawing Methods 0.000 claims description 2
- 238000009395 breeding Methods 0.000 claims 1
- 230000001488 breeding effect Effects 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 235000013325 dietary fiber Nutrition 0.000 abstract description 4
- 210000004072 lung Anatomy 0.000 abstract description 4
- 241000195493 Cryptophyta Species 0.000 abstract description 3
- 239000007787 solid Substances 0.000 abstract description 3
- 230000003014 reinforcing effect Effects 0.000 abstract description 2
- 240000008397 Ganoderma lucidum Species 0.000 abstract 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 3
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000010025 steaming Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 241000233866 Fungi Species 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 241000330899 Hepialus Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- 244000304222 Melaleuca cajuputi Species 0.000 description 1
- 235000001167 Melaleuca cajuputi Nutrition 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- -1 adenosine polysaccharide Chemical class 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000029771 childhood onset asthma Diseases 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229930182483 coumarin glycoside Natural products 0.000 description 1
- 150000008140 coumarin glycosides Chemical class 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 201000001981 dermatomyositis Diseases 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses soybean plantworms (or ganoderma lucidum or griflola frondosa) mycelium powder and a preparation method thereof. According to the present invention, the strain is the plantworms (or the ganoderma lucidum or the griflola frondosa); the preparation is solid fermentation. The preparation method comprises the following steps: carrying out soaking, sterilizing and steaming for soybean; cooling the soybean to a temperature of 25-28 DEG C; inoculating the industrial strain on the soybean ; placing the inoculated soybean into a container to carry out fermentation; inspecting adenosine, polysaccharide and the like when the surface of the soybean is covered with the mycelium, carrying out drying, sterilizing, packaging to prepare the finished product or the raw material after the adenosine, the polysaccharide and the like meet the requirements; or adding dietary fiber to the raw material to prepare the diet food; or adding barley seedling powder, spiral algae and the like to the raw material to prepare the alkaline food. The mycelium powder provided by the present invention has the following advantages that: protein content and amino acid content of the mycelium powder excess more than 50%, and are higher than the protein content and the amino acid content of pure soybean protein powder; the mycelium powder has functions of kidney tonifying and lung reinforcing, immune system regulating; the mycelium powder has the advantages of the soybean, and the advantages of the plantworms (or the ganoderma lucidum or the griflola frondosa).
Description
Technical field
Technical solutions according to the invention belong to the medical health care field, concretely, are to belong to contain from algae, lichen, fungus or plant or its derivatives field, according to International Patent Classification, belong to A61K 36/068 algae Cordyceps.
Background technology
1, Cordyceps.Be worm winter, be grass summer, mainly originate in areas such as the Qinghai of height above sea level more than 2000 meters, Tibet, wherein the quality with Qinghai cajaput and Cordyceps that Nagqu is produced is last, the larva that is Hepialus armorieanus Oberthur is formed by the fungus of Cordyceps Pseudomonas invasion back, and fungal mycelia is a food with the larva in-vivo tissue, grows in the larva body, to being full of polypide, worm is ossified.When warming up to the spring, grow a bar-shaped fungus Stroma from the Bombyx Batryticatus head, long 2～5 centimetres, ultimate swelling is an ascus, and spore has been full of softgel shell.From the shell of ascus, come out after the ascospore maturation, go to invade other larvas again, so produce new Cordyceps again.Spore is a seed.The medical value of Cordyceps: Cordyceps is the perfect combination of occurring in nature animal and plant, and it acts on human body and has one's own knack, vital essence replenishing and marrow benifiting, and this thing is protected the lung kidney, can control weakness.Modern medicine discovers that Cordyceps energy human body immunity improving function strengthens resistance against diseases, is a kind of rare precious Chinese medicine, and its purposes and value will be that more and more the people is familiar with and uses.Cordyceps main component: adenosine (cordycepin), mannitol (cordycepic acid), Cordyceps polysaccharide, several amino acids, vitamin and mineral etc.
The main effect of Cordyceps: Cordyceps is natural efficient immunomodulator, and its immunoregulation effect is two-way, and it can not only strengthen the immunity of human body, and to immunity state hyperthyroid, can produce the inhibitory action of appropriateness.Cordyceps is the natural antibiotics of the relative enrichment of occurring in nature.Cordyceps has inhibitory action to tens of kinds of pathogen such as streptococcus pneumoniae, streptococcus, staphylococcus aureuses, and more peculiar is to isolate from Cordyceps nineteen fifty-one the also effective antibiotic of tubercule bacillus---cordycepin.Cordyceps has certain antiinflammatory action.Its antiinflammatory action quite or surpass hydrogenation can alarmed and panicky.Cordyceps has blood vessel dilating, the effect of enhancing cardiopulmonary amount of blood supply of appropriateness: can make heart beating slack-off, but the output of painstaking effort obviously increases.Ancient medicine the secretary carried: " people suffers from pain in mind, fries in shallow oil soup with this worm and eats it, and is upright, never recurrence ".Pharmacological evaluation confirms that it is to action of the heart.Above-mentioned pharmacological action widely is for scientific basic has been established in Cordyceps treatment " weakness ".Prove that through clinical trial Cordyceps has following three big characteristics: (1) scope of application is wide, Cordyceps all has significant effect to respiratory system disease, kidney section disease, cardiovascular disease, hepatitis and liver cirrhosis, hematopathy, tumor and daily health caring; (2) adjuvant treatment effect is obvious; (3) have no side effect.
2, Ganoderma.Ganoderma is the treasure in motherland's pools of traditional Chinese medicine, have " Herba mesonae chinensis " reputation.Ganoderma have prevent and cure diseases, the effect of life lengthening.Modern pharmacology and clinical practice have further confirmed the pharmacological action of Ganoderma, and confirm that ganoderan is the main component of Ganoderma strengthening the body resistance, strengthening by means of tonics, life lengthening.Now, Ganoderma is formally recorded by state-promulgated pharmacopoeia as medicine, and it is again the new resource food of state approval simultaneously, has no side effect, can medicine-food two-purpose.The experimental result of R﹠D institution shows, the pharmaceutical component of Ganoderma is very abundant, wherein active ingredient can be divided into ten big classes, comprises ganoderan, Ganoderma polypeptide, triterpenes, 16 seed amino acids, mannitol, coumarin glycosides, alkaloid, organic acid (mainly containing Fumaric acid) and trace element.Ganoderma has dual regulation to human body, and the kind of curing the disease relates to each system such as cardiovascular and cerebrovascular vessel, digestion, nerve, endocrine, breathing, motion, and is especially very remarkable to the preventive and therapeutic effect of tumor, hepatic lesions, insomnia and aging.
The main effect of Ganoderma: the range of application of Ganoderma is very extensive.See that with regard to Chinese medical discrimination because this product goes into the five internal organs, the gas of completion body is so a little less than the heart, lung, liver,spleen,kidney deficiency of five ZANG-organs, all can obey it.Ganoderma is cured the disease and kind relates to breathing, circulation, digestion, nerve, endocrine and each system that moves, and contains inside and outside, woman, youngster, each section's disease of face.Its basic reason just is the Ganoderma strengthening the body resistance, and raise immunity improves Abwehrkraft des Koepers.It is different from general medicine certain disease is played therapeutical effect; also being different from general nutrition protects tendon food and only the deficiency of nutrient is in a certain respect replenished and strengthened; but two-ways regulation function of human body balance on the whole; transfer internal vigor in the body body; regulate human body metabolism function; improve the autoimmune ability, promote whole internal organs or organ function normalization.Clinical research proves that Ganoderma has the auxiliary treatment effect to multiple disease: (1) various tumors; (2) cardiovascular disease such as thrombosis, coronary heart disease, angina pectoris, hyperlipidemia, hypertension; (3) neurosis such as neurasthenia; (4) diseases such as frequency flu, hepatitis; (5) tracheitis, asthma, senile chronic bronchitis, childhood asthma; (6) diabetes, nephritis, endocrine disturbance; (7) leukopenia and aplastic anemia; (8) alopecia areata; (9) Keshan disease; (10) muscular dystrophy, rheumatism, rheumatoid arthritis, climacteric syndrome; (11) difficult and complicated illness such as chronic or locality scleroderma, dermatomyositis, lupus erythematosus, psoriasis all have good effect; (12) to the cancer patient put, physical rehabilitation after the chemotherapy has tangible effect, can shorten put, the toxicity time after the chemotherapy.
3, Grifola frondosa.The effect that Grifola frondosa has is anticancer, prevent and treat hypertension, hyperlipidemia, hyperglycemia, it can also prevent anemia, prevents that arteriosclerosis and cerebral thrombosis from taking place.Selenium and chromium content are higher, and the liver protecting, pancreas are arranged, the effect of prevention liver cirrhosis and diabetes.Its double calcic and vitamin D, both cooperate, and can effectively prevent rickets.The higher favourable brain development of zinc content, maintenance oxyopia promote wound healing.High-load vitamin E and selenium cooperate, and make people's energy defying age, memory reinforcing and sensitivity.
The pharmacological research of Grifola frondosa shows that also the contained active substance of Grifola frondosa mainly comprises polysaccharide, glycoprotein and some other enzyme, and wherein some metalloproteases has very strong antioxidant activity.The polysaccharide of Grifola frondosa is a kind of β-(1,3)-D-glucosan of originated from fungus, is natural small molecule bioactive material, and wherein some contains conjugated protein.This class material of discovered in recent years is not decomposed in gastrointestinal tract, has therefore kept active and also can be absorbed by the body, and has immunomodulating and function of tumor inhibition, is the strongest active a kind of polysaccharide.As a kind of material with many-sided physiologically active, grifolan can be applicable to functional food, drinks, also can be used as the additive of other food, can be used as medicine after the purification, is used for hypoimmunity disease, cancer prevention and treatment.
Grifolan has found to have following effect: (1) immunological enhancement; (2) suppress tumor; (3) anti AIDS virus; (4) blood sugar lowering; (5) bring high blood pressure down, blood fat and blood is glutinous; (6) alleviate the body weight of adiposis patient.The effect characteristics of grifolan: (1) immunologic pattern is anticancer; (2) high selectivity; (3) not only injectable but also can be oral; (4) high activity; The toxic and side effects of (5) reduction radiotherapy, chemotherapeutics.
Because Cordyceps is the elaboration in the Chinese Chinese medicine, artificial growth does not reach a standard, and therefore faces the danger of resource exhaustion, and price is expensive in gold.Country does not allow to do the raw material production product with Cordyceps for the consideration of resource conservation, protection environment, and the present invention is an outlet that solves this predicament.
To also have the mushroom of similar functions to also have a lot of with Cordyceps, the Ganoderma that relates to as present technique, Grifola frondosa etc., but they can both artificial growth, and price is basicly stable.
Existing Cordyceps powder be leach behind the liquid fermentation, dry or with the product that extracts behind the impurity solid fermentation, be as described in 200710149372.0 " refined Chinese caterpillar fungus powder and the preparation methoies " as China's patent No..Its weak point is the cost height, waste energy, whether product contains adenosine, and (State Food and Drug Administration draws up the index of unique affirmation true and false to Cordyceps) is unintelligible.It is to make with the wild cordyceps pulverizing that some products are arranged again, and this is prohibited by country.
Summary of the invention
The objective of the invention is the urgent needs to health at the deficiency that exists on the prior art and people, provide a kind of can mass production, high-quality Semen sojae atricolor Cordyceps (or Ganoderma or Grifola frondosa) sporophore product.When this goods are not pulverized granulate " Chinese natto "; When pulverizing to powder is Semen sojae atricolor Cordyceps (or Ganoderma or Grifola frondosa) mycelium powder.
The object of the present invention is achieved like this: the generation of Semen sojae atricolor Cordyceps (or Ganoderma or Grifola frondosa) mycelium powder, be to be the fermentation culture strain with Cordyceps strain (or Ganoderma or Grifola frondosa), after finishing the work, the Semen sojae atricolor Cordyceps of generation (or Ganoderma or Grifola frondosa) its mass percent of mycelium powder is as follows: cordycepin (adenosine) positive; Cordyceps (or Ganoderma or Grifola frondosa) polysaccharide 2～10%; Protein 10～20%; Free amino acid 3～10%; Soybean isoflavone 0.1～0.5%; Soyasaponins 0.6～6%; Soybean oligo saccharide 2～10%; Unsaturated fatty acid 2～10%; VE, VB0.01～0.06%; Surplus: soybean protein powder.
Semen sojae atricolor Cordyceps (or Ganoderma or Grifola frondosa) mycelium powder preparation method.Stand-by with strain preparation commercial production such as Cordyceps or Ganoderma or Grifola frondosa with strain; After in addition Semen sojae atricolor or Semen sojae atricolor, Semen Glycines, Semen phaseoli radiati etc. being soaked 1～2 hour, sterilization (high temperature, long-time) is also removed the enzyme and the bean stink smell of unfavorable absorption of human body in the Semen sojae atricolor, simultaneously Semen sojae atricolor has been cooked.Go out to sterilize cabinet cold to 25 ℃～28 ℃ can be inoculated commercial production with strain (liquid or solid), puts into container tray (available rustless steel or edible plastic goods), ferments, and this pallet can leave standstill also can put to shake on the shaking table or put into cylinder and ferment.The different strain fermentation time is different with temperature, about 25 ℃ of Cordyceps, 3～15 days; About 28 ℃ of Ganoderma, 5～20 days; About 28 ℃ of Grifola frondosa, 3～15 days.Outside Semen sojae atricolor, cover with Cordyceps mycelium, be clamminess in the time of can pulling out thread, finish fermentation, indexs such as check adenosine polysaccharide, reach requirement after, can dry, sterilize, pack.Be finished product this moment, also raw material.Continue deep processing adding dietary fiber and become diet food, make baked goods such as bread, cookies, electuary powder, puffed food, snack food, also but deep processing adds base-forming food base forming foods such as Herba Hordei Vulgaris powder, spirulina, cyanophyceae, makes powdered agent, baked goods, puffed food, snack food.
Advantage of the present invention: this goods soybean protein amino acid content surpasses 50%, is better than the soybean protein powder, has the effect of the kidney invigorating lung benefiting, adjustment immunologic function, has promptly both contained the advantage of Semen sojae atricolor, contains the advantage of Cordyceps again.This goods also can be made into capsule, tablet, powder; Also can make safe diet food in conjunction with dietary fiber as substrate; Make basic food in conjunction with Herba Hordei Vulgaris powder etc., alleviate acidic physique problems such as gout.But these food electuaries, baked goods (as bread, cookies etc.) or puffed food (as rice crust, shrimp cracker etc.), snack food.
The specific embodiment
A kind of Semen sojae atricolor Cordyceps mycelium powder, strain are Cordyceps, and the Semen sojae atricolor Cordyceps mycelium powder is formed, and its mass percent is as follows:
Cordycepin (adenosine) positive
Cordyceps polysaccharides 2～10%
Protein 10～20%
Free amino acid 3～10%
Soybean isoflavone 0.1～0.5%
Soyasaponins 0.6～6%
Soybean oligo saccharide 2～10%
Unsaturated fatty acid 2～10%
VE、VB 0.01～0.06％
Surplus: soybean protein powder.
Strain is a Ganoderma, and Semen sojae atricolor Ganoderma mycelium powder is formed, and its mass percent is as follows:
Ganoderan 2～10%
Protein 10～20%
Free amino acid 3～10%
Soybean isoflavone 0.1～0.5%
Soyasaponins 0.6～6%
Soybean oligo saccharide 2～10%
Unsaturated fatty acid 2～10%
VE、VB 0.01～0.06％
Surplus: soybean protein powder.
Strain is a Grifola frondosa, and Semen sojae atricolor maitake mushroom mycelia powder is formed, and its mass percent is as follows:
Grifolan 2～10%
Protein 10～20%
Free amino acid 3～10%
Soybean isoflavone 0.1～0.5%
Soyasaponins 0.6～6%
Soybean oligo saccharide 2～10%
Unsaturated fatty acid 2～10%
VE、VB 0.01～0.06％
Surplus: soybean protein powder.
Semen sojae atricolor Cordyceps (or Ganoderma or Grifola frondosa) mycelium powder preparation method.
Embodiment 1:
(1) Cordyceps strain is expanded as the commercial production strain, needed about 20 days approximately; Take out Cordyceps strain from refrigerator earlier, remove hibernation-like state through 7～8 days, be seeded to 50～80 test tube slants, again through after 15 days, the strain of test tube slant enters and shakes bottle for a short time, shakes bottle or seed tank greatly, makes commercial production reach 5%～30% of Semen sojae atricolor quality with the strain amount; (2) Cordyceps strain can use preceding 4～6 hours, and the beginning soaking soybean soaked after 1～2 hour, and the Semen sojae atricolor of swelling is put into the sterilization cabinet, kept about 121 ℃, sterilized through 30 minutes and cooked; (3) the Semen sojae atricolor taking-up that cooks is cooled to about 25 ℃, stir on the limit, and the limit is spilled into Cordyceps strain to mix homogeneously, and the stainless steel disc of packing into, the diameter of the abundant oxygen supply when being beneficial to ferment of gathering on this stainless steel disc are 1 millimeter aperture; (4) approximately cover 16 layers of gauze on the stainless steel disc, put into the sweathouse fermentation, sweathouse is about 300,000 grades of clean rooms, about 25 ℃ of constant temperature, and humidity 75%～90%, through 3～7 days, the white hypha body was covered with the Semen sojae atricolor surface, and the wire drawing phenomenon is arranged, and promptly finished fermentation; (5) composition is surveyed in censorship, oven dry, and pulverizing can be packed, and becomes the Semen sojae atricolor Cordyceps mycelium powder, also can make granulate " Chinese Cordyceps natto " with not pulverizing after the oven dry of Semen sojae atricolor Cordyceps mycelium powder.
Embodiment 2
With embodiment 1, but strain is a Ganoderma.Fermentation temperature is about 28 ℃.After finishing fermentation in 4～8 days, be Semen sojae atricolor Ganoderma mycelium powder or granulate " Chinese Ganoderma natto ".
Embodiment 3
With embodiment 1, but strain is a Grifola frondosa.Fermentation temperature is about 28 ℃.After finishing fermentation in 3～7 days, be Semen sojae atricolor maitake mushroom mycelia powder or granulate " Chinese Grifola frondosa natto ".
Embodiment 4
The Semen sojae atricolor Cordyceps mycelium powder that obtains in the foregoing description 1,2,3, Semen sojae atricolor Ganoderma mycelium powder and Semen sojae atricolor maitake mushroom mycelia powder can be made into capsule, and equipment is production line soft, hard capsule, can produce the soft or hard capsule of different size, and finish packing.
Embodiment 5
The Semen sojae atricolor Cordyceps mycelium powder that obtains in the foregoing description 1,2,3, Semen sojae atricolor Ganoderma mycelium powder and Semen sojae atricolor maitake mushroom mycelia powder can add 10～30% human consumption soybean fiber, and mixed powder is broken into 100～200 order powder, makes diet food.At this moment, protein content 20%～30%, dietary fiber content 15%～35%, and contain unsaturated fatty acid, lecithin, soybean isoflavone, Saponin, vitamin, trace element-selenium, ferrum, zinc, calcium etc., have prescribing adequate nutrition, but heat is not high; In addition, the mushroom polysaccharide can improve immunity, adjusts self equilibrium between yin and yang, has guaranteed safe fat-reducing, has improved health.
Embodiment 6
Can be made into various slimming capsules in the foregoing description 4, embodiment 5 Joint Implementations, as fat-reducing Semen sojae atricolor Cordyceps mycelium, fat-reducing Semen sojae atricolor Ganoderma mycelium, soft, the hard capsule of fat-reducing maitake mushroom mycelia.
Embodiment 7
Fat-reducing Semen sojae atricolor Cordyceps mycelium powder in the foregoing description 5, fat-reducing Ganoderma mycelium powder, fat-reducing maitake mushroom mycelia powder can be made into baked goods (as bread, cookies etc.), puffed food (as rice crust, shrimp cracker etc.) and various snack food, keep on a diet to make things convenient for the slimmer.When edible these diet food, can replenish vegetable, fruit and great quantity of water drinking, more than the every day 2500ml.
Embodiment 8
Semen sojae atricolor Cordyceps mycelium powder in the foregoing description 1,2,3, Semen sojae atricolor Ganoderma mycelium powder, Semen sojae atricolor maitake mushroom mycelia powder are equipped with 10～50% Herba Hordei Vulgaris powder, make basic food, alkalescence Semen sojae atricolor Cordyceps mycelium powder, alkaline Semen sojae atricolor Ganoderma mycelium powder, alkaline Semen sojae atricolor maitake mushroom mycelia powder, these basic foods can improve other ailing symptom that gout symptom and acidic physique cause.Also available other basic food of Herba Hordei Vulgaris powder replenishes replacement as green vegetable, Sargassum.
Embodiment 9
Alkaline Semen sojae atricolor Cordyceps mycelium powder in the foregoing description 8, alkaline Semen sojae atricolor Ganoderma mycelium powder, alkaline Semen sojae atricolor maitake mushroom mycelia powder, press the method for embodiment 4, can obtain various basic food capsules, as alkaline Semen sojae atricolor Cordyceps mycelium, alkaline Semen sojae atricolor Ganoderma mycelium, soft, the hard capsule of alkaline Semen sojae atricolor maitake mushroom mycelia.
Embodiment 10
Alkaline Semen sojae atricolor Cordyceps mycelium powder in the foregoing description 8, alkaline Semen sojae atricolor Ganoderma mycelium powder, alkaline Semen sojae atricolor maitake mushroom mycelia powder can be made into baked goods, and puffed food and other snack food are edible to make things convenient for consumer.
Claims (9)
1. Semen sojae atricolor Cordyceps mycelium powder, it is characterized in that: strain is a Cordyceps, by mass percentage, the Semen sojae atricolor Cordyceps mycelium powder is composed as follows:
Cordycepin (adenosine) positive
Cordyceps polysaccharides 2～10%
Protein 10～20%
Free amino acid 3～10%
Soybean isoflavone 0.1～0.5%
Soyasaponins 0.6～6%
Soybean oligo saccharide 2～10%
Unsaturated fatty acid 2～10%
VE、VB 0.01～0.06％
Surplus: soybean protein powder.
2. according to the described Semen sojae atricolor Cordyceps mycelium powder of claim 1, it is characterized in that: Semen sojae atricolor Ganoderma mycelium powder, described strain are Ganoderma, and its polysaccharide is a ganoderan, and shared percentage ratio is 2～10%.
3. according to the described Semen sojae atricolor Cordyceps mycelium powder of claim 1, it is characterized in that: Semen sojae atricolor maitake mushroom mycelia powder, described strain are Grifola frondosa, and its polysaccharide is a grifolan, and shared percentage ratio is 2～10%.
4. Semen sojae atricolor Cordyceps mycelium powder preparation method, it is characterized in that: (1) expands as the commercial production strain with Cordyceps strain, needs 20 days approximately; Take out Cordyceps strain from refrigerator earlier, through 7～8 days releasing hibernation-like states, be seeded to 50～80 test tube slants, again through after 15 days, the strain of test tube slant enter shake for a short time the bottle, greatly shake the bottle or seed tank, a large amount of breeding strains make commercial production reach 5%～30% of Semen sojae atricolor quality with the strain amount; (2) Cordyceps strain can use preceding 4～6 hours, and the beginning soaking soybean soaked after 1～2 hour, and the Semen sojae atricolor of swelling is put into the sterilization cabinet, kept about 121 ℃, sterilized through 30 minutes and cooked; (3) the Semen sojae atricolor taking-up that cooks is cooled to about 25 ℃, stir on the limit, and the limit is spilled into Cordyceps strain to mix homogeneously, and the stainless steel disc of packing into, the diameter of the abundant oxygen supply when being beneficial to ferment of gathering on this stainless steel disc are 1 millimeter aperture; (4) approximately cover 16 layers of gauze on the stainless steel disc, put into the sweathouse fermentation, sweathouse is 300,000 grades of clean rooms, about 25 ℃ of constant temperature, and humidity 75%～90%, through 3～7 days, the white hypha body was covered with the Semen sojae atricolor surface, and the wire drawing phenomenon is arranged, and promptly finished fermentation; (5) composition is surveyed in censorship, oven dry, and pulverizing can be packed, and becomes the Semen sojae atricolor Cordyceps mycelium powder, also can make granulate " Chinese Cordyceps natto " with not pulverizing after the oven dry of Semen sojae atricolor Cordyceps mycelium powder.
5. according to the described Semen sojae atricolor Cordyceps mycelium powder of claim 4 preparation method, it is characterized in that: described strain is a Ganoderma, and fermentation temperature is about 28 ℃, after fermentation in 4～8 days, makes Semen sojae atricolor Ganoderma mycelium powder or granulate " Chinese Ganoderma natto ".
6. according to the described Semen sojae atricolor Cordyceps mycelium powder of claim 4 preparation method, it is characterized in that: described strain is a Grifola frondosa, and fermentation temperature is about 28 ℃.After fermentation in 3～7 days, make Semen sojae atricolor maitake mushroom mycelia powder or granulate " Chinese Grifola frondosa natto ".
7. according to claim 4 or 5 or 6 described Semen sojae atricolor Cordyceps mycelium powder preparation methoies, it is characterized in that: described Semen sojae atricolor Cordyceps mycelium powder, Semen sojae atricolor Ganoderma mycelium powder or Semen sojae atricolor maitake mushroom mycelia powder, make soft capsule or hard capsule.
8. according to claim 4 or 5 or 6 described Semen sojae atricolor Cordyceps mycelium powder preparation methoies, it is characterized in that: described Semen sojae atricolor Cordyceps mycelium powder, Semen sojae atricolor Ganoderma mycelium powder or Semen sojae atricolor maitake mushroom mycelia powder add 10～30% human consumption soybean fiber, mixed powder is broken into 100～200 order powder, make diet food, also can be made into various soft, hard slimming capsules, as fat-reducing Semen sojae atricolor Cordyceps mycelium capsule, fat-reducing Semen sojae atricolor Ganoderma mycelium body capsule, fat-reducing maitake mushroom mycelia capsule; Fat-reducing Semen sojae atricolor Cordyceps mycelium powder, fat-reducing Ganoderma mycelium powder, fat-reducing maitake mushroom mycelia powder can be made baked goods again,, or make puffed food as bread or cookies, as rice crust, shrimp cracker, and various snack food.
9. according to claim 4 or 5 or 6 described Semen sojae atricolor Cordyceps mycelium powder preparation methoies, it is characterized in that: described Semen sojae atricolor Cordyceps mycelium powder, Semen sojae atricolor Ganoderma mycelium powder, Semen sojae atricolor maitake mushroom mycelia powder are equipped with 10～50% Herba Hordei Vulgaris powder, make basic food, alkalescence Semen sojae atricolor Cordyceps mycelium powder, alkaline Semen sojae atricolor Ganoderma mycelium powder, alkaline Semen sojae atricolor maitake mushroom mycelia powder, the also available green vegetable of Herba Hordei Vulgaris powder, Sargassum replace; Described alkaline Semen sojae atricolor Cordyceps mycelium powder, alkaline Semen sojae atricolor Ganoderma mycelium powder, alkaline Semen sojae atricolor maitake mushroom mycelia powder, make various soft, hard base food capsules,, hard capsule soft as alkaline Semen sojae atricolor Cordyceps mycelium, alkaline Semen sojae atricolor Ganoderma mycelium are soft, hard capsule, soft, the hard capsule of alkaline Semen sojae atricolor maitake mushroom mycelia, also can be made into baked goods, puffed food and other snack food.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010199789XA CN102274271B (en) | 2010-06-13 | 2010-06-13 | Soybean plantworms mycelium powder and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010199789XA CN102274271B (en) | 2010-06-13 | 2010-06-13 | Soybean plantworms mycelium powder and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102274271A true CN102274271A (en) | 2011-12-14 |
| CN102274271B CN102274271B (en) | 2013-08-14 |
Family
ID=45100217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010199789XA Expired - Fee Related CN102274271B (en) | 2010-06-13 | 2010-06-13 | Soybean plantworms mycelium powder and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102274271B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103190576A (en) * | 2013-04-27 | 2013-07-10 | 青岛农业大学 | Cordyceps militaris soybean and preparation method thereof |
| CN103621941A (en) * | 2013-11-19 | 2014-03-12 | 吴万和 | Edible fungi cake and baking method thereof |
| CN103652559A (en) * | 2013-12-11 | 2014-03-26 | 罗永祺 | Blood tonifying and nourishing chewable tablets and preparation method |
| CN104206175A (en) * | 2014-09-12 | 2014-12-17 | 山东建筑大学 | Method for coproducing cordyceps militaris and health cordyceps militaris bread |
| CN105286014A (en) * | 2015-10-21 | 2016-02-03 | 湖北省农业科学院农产品加工与核农技术研究所 | Production method of Cordyceps militaris-Bafillus natto compound fermented functional raw-food material |
| CN106879902A (en) * | 2017-02-17 | 2017-06-23 | 陕西必康制药集团控股有限公司 | Barley seedling powder solid beverage with and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101724563A (en) * | 2008-10-10 | 2010-06-09 | 深圳市每人康生物科技有限公司 | Cordyceps sinensis mycelium powder and preparation method thereof |
-
2010
- 2010-06-13 CN CN201010199789XA patent/CN102274271B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101724563A (en) * | 2008-10-10 | 2010-06-09 | 深圳市每人康生物科技有限公司 | Cordyceps sinensis mycelium powder and preparation method thereof |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103190576A (en) * | 2013-04-27 | 2013-07-10 | 青岛农业大学 | Cordyceps militaris soybean and preparation method thereof |
| CN103621941A (en) * | 2013-11-19 | 2014-03-12 | 吴万和 | Edible fungi cake and baking method thereof |
| CN103652559A (en) * | 2013-12-11 | 2014-03-26 | 罗永祺 | Blood tonifying and nourishing chewable tablets and preparation method |
| CN104206175A (en) * | 2014-09-12 | 2014-12-17 | 山东建筑大学 | Method for coproducing cordyceps militaris and health cordyceps militaris bread |
| CN104206175B (en) * | 2014-09-12 | 2016-04-27 | 山东建筑大学 | A kind of coproduction makes the method for Cordyceps militaris and health care Cordyceps militaris bread |
| CN105286014A (en) * | 2015-10-21 | 2016-02-03 | 湖北省农业科学院农产品加工与核农技术研究所 | Production method of Cordyceps militaris-Bafillus natto compound fermented functional raw-food material |
| CN106879902A (en) * | 2017-02-17 | 2017-06-23 | 陕西必康制药集团控股有限公司 | Barley seedling powder solid beverage with and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102274271B (en) | 2013-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101279959B1 (en) | Manufacturing Method of Fermented Materials using Wax Gourd and Functional food of Thereof Manufacturing | |
| CN102274271B (en) | Soybean plantworms mycelium powder and preparation method thereof | |
| CN103299887B (en) | Method for preparing phellinus igniarius hypha blocks by utilizing sprouted rice | |
| CN102648751B (en) | Engineering rice with functions of alleviating hangover and protecting liver and preparation method of engineering rice | |
| CN103484330A (en) | Method for preparing brown rice phellinus wine | |
| CN104770499A (en) | Cistanche or cynomorium songaricum ferment tea and manufacturing method thereof | |
| CN107927512A (en) | A kind of oligopeptide weight losing meal-replacing solid beverage | |
| CN106616947A (en) | Cordyceps militaris composition | |
| CN104342350A (en) | Brewing method of coix seed and glossy ganoderma wine | |
| CN103468515A (en) | Brown rice-ganoderma lucidum wine and brewing method thereof | |
| CN104106372A (en) | Lucid ganoderma mycelium and method for preparing lucid ganoderma mycelium body | |
| CN103919013A (en) | Processing method for ganoderma corn flour | |
| CN107259329A (en) | A kind of preparation method of the thick various grains gruel material of Cordyceps militaris | |
| CN106134765A (en) | A kind of Ganoderma Folium hydrangeae strigosae Cordyceps mycelium | |
| CN106119126A (en) | A kind of Moringa Ganoderma mycelium | |
| CN109536351A (en) | A kind of brown rice phellinus wine | |
| CN108354168A (en) | A kind of Phellinus bacterium nutrient tablet and preparation method thereof | |
| CN107997125A (en) | Edible mushroom mycelium and or edible mushroom mycelium powder manufacture craft and products thereof | |
| CN103932172A (en) | Cordyceps health-care product and preparation method thereof | |
| CN105941768A (en) | Camellia chrysantha tuyama containing ganoderma lucidum hyphae | |
| CN106071584A (en) | Ganoderma biotype beverage is cultivated for carrier with brown rice | |
| CN106107370A (en) | A kind of Fructus Mali pumilae Liquid Strain of Ganoderma Lucidum converts beverage | |
| CN106107356A (en) | Cordyceps biotype beverage is cultivated for carrier with brown rice | |
| CN105361149A (en) | Highland barley-Chinese caterpillar fungus nutrition powder and preparation method thereof | |
| CN104403898A (en) | Brown rice and phellinus igniarius wine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160525 Address after: 438699, Huanggang, Hubei County, Luotian province Fengshan town rabbit rabbit Lane No. 2-3 Patentee after: Yuan Yuquan Address before: East China Science and Technology Industrial Park in Longgang District of Shenzhen City, Guangdong province 518038 Henggang Dakang No. 5 Patentee before: Shenzhen Meirenkang Biological Technology Co., Ltd. Effective date of registration: 20160525 Address after: 438699, Huanggang, Hubei County, Luotian province Fengshan town rabbit rabbit Lane No. 2-3 Patentee after: Yuan Yuquan Address before: East China Science and Technology Industrial Park in Longgang District of Shenzhen City, Guangdong province 518038 Henggang Dakang No. 5 Patentee before: Shenzhen Meirenkang Biological Technology Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130814 Termination date: 20190613 |